Angiotensin receptor blockers: current status and future prospects.
about
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapyThe differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetesInhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.Differential pharmacology and benefit/risk of azilsartan compared to other sartansAstragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats.Therapeutic inhibition of the renin angiotensin aldosterone system.Next generation multifunctional angiotensin receptor blockers.Losartan chemistry and its effects via AT1 mechanisms in the kidneyThe role of angiotensin receptor blockers in diabetic nephropathy.Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)-irbesartan complex: structure-antihypertensive activity relationships in Cu(II)-sartan complexes.Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
P2860
Q26751126-A1D1B4F6-2E06-459E-8A4D-3FADB6303D52Q34135967-F4D6AA8A-CD68-46A4-BD07-5DE12418C11BQ35661331-B13A3945-B27E-4863-AD90-8FD76873BDDCQ35808748-AA7D2251-4EE2-4895-893D-1C75BE9EB10BQ37448086-A58A73D5-B42A-4637-8B21-0CD92E6651BFQ37489951-3EE14B1F-DB1D-414E-8DFC-BFEF56EA91A9Q37588484-87BE7174-ACC2-43C0-9139-C7B9F074A2C4Q37595616-FB9B813F-EBA0-4E7E-A96D-772C1F69E496Q37874892-4B4CC2DB-E178-4DF3-BA91-041FB46E6D1CQ38098984-A898CF2F-13B0-4DB7-8CC7-E16570C871BAQ38752809-DF45CB61-FB10-478C-82AC-55048B464832Q40895409-D19FA3ED-BF8F-43D6-B46A-558468950749Q41606804-9D38B1CE-D75F-4387-BF57-2E393F304126Q41652967-CC6B00DC-E8E8-415A-9C04-30402F614881Q42776028-481BA98B-9B62-4D32-9027-DA8BF97958BC
P2860
Angiotensin receptor blockers: current status and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin receptor blockers: current status and future prospects.
@en
Angiotensin receptor blockers: current status and future prospects.
@nl
type
label
Angiotensin receptor blockers: current status and future prospects.
@en
Angiotensin receptor blockers: current status and future prospects.
@nl
prefLabel
Angiotensin receptor blockers: current status and future prospects.
@en
Angiotensin receptor blockers: current status and future prospects.
@nl
P1476
Angiotensin receptor blockers: current status and future prospects.
@en
P2093
C Venkata S Ram
P304
P356
10.1016/J.AMJMED.2008.02.038
P407
P577
2008-08-01T00:00:00Z